Instituto de Tecnologia Química e Biológica António Xavier, ITQB NOVA, Universidade Nova de Lisboa, Oeiras, Portugal.
Columbia University Irving Medical Center, New York, New York.
Curr Protoc. 2022 Jun;2(6):e458. doi: 10.1002/cpz1.458.
Mycobacterium tuberculosis, the etiological agent of tuberculosis, is regarded as the most successful pathogen of humankind and a major threat to global health. The mycobacterial cell wall is vital for cell growth, virulence, and resistance to antibiotics, and thus constitutes a unique target for drug development. To characterize the enzymes catalyzing the synthesis of the cell wall components, considerable amounts of substrates are required. Since many mycobacterial cell wall lipids, particularly phosphatidylinositol mannosides (PIMs), are not commercially available, isolation from cell biomass is the most straightforward way to obtain these compounds. In this study, we optimized a protocol to extract and purify PIM species, in particular Ac PIM and Ac PIM , which can be further used for the identification and characterization of target enzymes. PIMs were extracted from Mycobacterium smegmatis mc 155 ΔPimE using organic solvents, and purified through three consecutive chromatography steps. Thin-layer chromatography (TLC) was used in-between purification steps to evaluate the success of lipid separation, and nuclear magnetic resonance (NMR) was used for product quantification and to assess purity. Typically, from a 60 g batch of M. smegmatis biomass we were able to isolate approximately 9 mg of Ac PIM and 1.8 mg of Ac PIM . This is the first time the purification of phosphatidylinositol tetramannoside has been reported. © 2022 Wiley Periodicals LLC. Basic Protocol 1: Growth of M. smegmatis mc 155 ∆PimE Basic Protocol 2: Extraction of lipids from M. smegmatis mc 155 ∆PimE Basic Protocol 3: Treatment of the lipid extract for isolation of phospholipids Basic Protocol 4: Isolation of phosphatidylinositol mannosides Basic Protocol 5: Quantification of phosphatidylinositol mannosides.
结核分枝杆菌是结核病的病原体,被认为是人类最成功的病原体,也是全球健康的主要威胁。分枝杆菌细胞壁对于细胞生长、毒力和抗生素耐药性至关重要,因此构成了药物开发的独特靶点。为了表征催化细胞壁成分合成的酶,需要大量的底物。由于许多分枝杆菌细胞壁脂质,特别是磷酸肌醇甘露糖苷(PIMs),没有商业来源,因此从细胞生物量中分离是获得这些化合物的最直接方法。在这项研究中,我们优化了一种从分枝杆菌中提取和纯化 PIM 种的方案,特别是 Ac PIM 和 Ac PIM ,可进一步用于目标酶的鉴定和表征。使用有机溶剂从耻垢分枝杆菌 mc 155ΔPimE 中提取 PIMs,并通过三个连续的色谱步骤进行纯化。在纯化步骤之间使用薄层层析(TLC)来评估脂质分离的成功,并用核磁共振(NMR)进行产物定量和评估纯度。通常,从 60 g 批的耻垢分枝杆菌生物量中,我们能够分离出约 9 mg 的 Ac PIM 和 1.8 mg 的 Ac PIM 。这是首次报道磷酸肌醇四甘露糖苷的纯化。© 2022 Wiley Periodicals LLC. 基本方案 1:耻垢分枝杆菌 mc 155ΔPimE 的生长 基本方案 2:耻垢分枝杆菌 mc 155ΔPimE 中脂质的提取 基本方案 3:处理脂质提取物以分离磷脂 基本方案 4:磷酸肌醇甘露糖苷的分离 基本方案 5:磷酸肌醇甘露糖苷的定量。